Vimta Labs Limited
NSE: VIMTALABSINE579C01029·Healthcare·www.vimta.com ↗·Mcap ₹2,725 Cr·Listed 2005
₹599.30▲ ₹1.80  (0.30%)
52W: ₹376 – ₹775 · Vol: 1.5L shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q1 FY19
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q1 FY19
Revenue from operations10910998.610297.694.488.583.180.278.380.172.382.280.876.579.173.666.774.76159.558.258.832.643.251.542.54453.654.5
Other income3.82.81.82.71.71.61.20.70.70.50.920.60.71.10.80.40.70.10.20.20.300.21.70.80.40.20.20.7
Total expenses84.582.975.578.274.171.166.562.865.263.368.466.567.265.563.962.357.752.160.850.249.347.949.135.144.746.242.342.645.446.9
EBITDA37.339.434.234.233.73332.328.923.623.620.915.323.823.62125.123.120.419.616.716.716.615.83.7511.56.37.313.914.2
EBITDA margin34.2%36.0%34.7%33.6%34.5%35.0%36.5%34.8%29.4%30.2%26.1%21.2%29.0%29.2%27.5%31.7%31.3%30.6%26.3%27.4%28.0%28.5%26.9%11.2%11.5%22.3%14.9%16.5%25.9%26.0%
Finance costs0.20.30.20.40.30.40.60.40.50.50.50.60.40.20.70.80.60.20.20.40.70.60.30.61.20.910.60.41.8
Depreciation12.512.810.910.29.99.29.78.28.188.68.98.587.87.56.65.55.55.55.85.75.85.65.35.35.25.25.24.7
Profit before tax28.32923.426.325.32523.22115.715.612.67.815.51613.717.616.315.312.810.910.410.69.7−2.30.26.10.51.68.48.4
Tax7.37.95.86.46.46.76.24.643.83.11.93.93.73.74.54.43.83.32.82.72.62.4−0.501.4−0.40.41.61.9
Net profit2121.117.619.918.918.32114.611.611.89.55.911.612.31013.111.911.69.58.17.787.4−1.90.14.70.91.26.86.5
Net margin19.3%19.3%17.8%19.6%19.4%19.4%23.7%17.5%14.5%15.1%11.8%8.2%14.1%15.2%13.0%16.5%16.1%17.3%12.7%13.3%13.0%13.8%12.5%-5.8%0.3%9.2%2.1%2.7%12.6%11.8%
EPS (₹)4.714.733.964.464.258.227.657.385.255.344.262.675.255.544.505.915.375.234.303.673.503.623.34-0.850.062.130.410.533.062.92
Net profit YoY+11.4%+15.3%−16.3%+36.6%+62.3%+55.2%+122.3%+146.3%+0.1%−3.7%−5.0%−54.7%–+3.1%−13.9%+37.3%+53.3%+44.3%+29.0%+532.3%+5355.6%+70.0%+716.8%−260.3%−97.9%––−81.9%––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19
Revenue from operations407344313315276209181213
Other income94.243.51.50.831.9
Total expenses311259265255221181175179
EBITDA14212283.693.579.852.73057.5
EBITDA margin34.7%35.5%26.7%29.7%28.9%25.2%16.6%27.1%
Finance costs1.21.92.12.61.52.23.84.6
Depreciation43.835.33430.523.222.920.919.7
Profit before tax1048951.563.855.328.48.335.1
Tax26.422.212.716.514.37.11.49.8
Net profit77.567.338.847.341.121.36.925.3
Net margin19.0%19.6%12.4%15.0%14.9%10.2%3.8%11.9%
EPS (₹)17.4030.0217.5221.3718.579.623.1311.45
Net profit YoY+15.1%+73.5%−18.0%+15.2%+93.1%+206.9%−72.6%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow14794.659.186.558.7
Investing cash flow−130−75.5−74.6−56.9−37.9
Financing cash flow−10.4−16.7−1.9−10.7−16.1
Capital expenditure99.779.175.247.829.7
Free cash flow (CFO − capex)47.515.5−16.138.729

Net profit trend

annual, ₹ crore
FY21
₹21.3
FY22
₹41.1+93%
FY23
₹47.3+15%
FY24
₹38.8−18%
FY25
₹67.3+74%
FY26
₹77.5+15%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone20 Jul 2026PDF on NSE XBRL
Q4 FY26Standalone · audited6 May 2026PDF on NSE XBRL
Q3 FY26Standalone28 Jan 2026PDF on NSE XBRL
Q2 FY26Standalone3 Nov 2025PDF on NSE XBRL
Q1 FY26Standalone17 Jul 2025PDF on NSE XBRL
Q4 FY25Standalone · audited–PDF on NSE XBRL
Q4 FY25Standalone · audited29 Apr 2025PDF on NSE XBRL
Q3 FY25Consolidated24 Jan 2025PDF on NSE XBRL
Q3 FY25Standalone24 Jan 2025PDF on NSE XBRL
Q2 FY25Consolidated8 Nov 2024PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)33.6×
P/B5.86×
ROEFY26, on average equity18.5%
Net margin19.0%
Debt / equity0.01×
Revenue CAGR (3Y)8.9%
Profit CAGR (3Y)17.9%
EPS (TTM)₹17.83
Market cap₹2,677 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
Balance sheet 31 Mar 2026
Total assets₹562 Cr+21%
Net worth₹457 Cr+21%
Total borrowings₹3 Cr−61%
Cash & bank balances₹23 Cr+45%
Investments₹2 Cr
Inventories₹30 Cr+20%
Trade receivables₹106 Cr−1%
Trade payables₹12 Cr+11%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter35.6735.8535.9035.9936.6736.6736.7036.7636.8936.8936.9236.98
FII4.424.894.594.333.493.523.663.813.315.165.132.88
DII0.370.140.110.871.421.421.431.160.001.491.501.49
of which MF0.200.000.000.000.00–––––––
Retail25.0325.0125.1224.6224.0123.9025.1725.0926.5323.1223.0725.15
Other public34.5134.1134.2834.1934.4134.4933.0433.1833.2733.3433.3833.50
50,190 shareholders · NSE shareholding pattern filings.